RTW vs. PMGR, DVNO, TEK, TPVE, YOLO, FFWD, KZG, JTWO, VEN2, and SVCT
Should you be buying RTW Biotech Opportunities stock or one of its competitors? The main competitors of RTW Biotech Opportunities include Premier Miton Glb Renewables Trust (PMGR), Develop North (DVNO), Tekcapital (TEK), Triple Point Income VCT Plc E (TPVE), Yolo Leisure and Technology (YOLO), Fastforward Innovations (FFWD), Kazera Global (KZG), J2 Acquisition (JTWO), Ventus 2 VCT (VEN2), and Seneca Growth Capital VCT (SVCT). These companies are all part of the "asset management" industry.
RTW Biotech Opportunities vs. Its Competitors
RTW Biotech Opportunities (LON:RTW) and Premier Miton Glb Renewables Trust (LON:PMGR) are both small-cap financial services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.
0.0% of RTW Biotech Opportunities shares are held by institutional investors. Comparatively, 6.6% of Premier Miton Glb Renewables Trust shares are held by institutional investors. 0.6% of RTW Biotech Opportunities shares are held by company insiders. Comparatively, 1.8% of Premier Miton Glb Renewables Trust shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
RTW Biotech Opportunities has a net margin of 664.38% compared to Premier Miton Glb Renewables Trust's net margin of 133.43%. RTW Biotech Opportunities' return on equity of 25.18% beat Premier Miton Glb Renewables Trust's return on equity.
In the previous week, RTW Biotech Opportunities had 2 more articles in the media than Premier Miton Glb Renewables Trust. MarketBeat recorded 2 mentions for RTW Biotech Opportunities and 0 mentions for Premier Miton Glb Renewables Trust. RTW Biotech Opportunities' average media sentiment score of 0.80 beat Premier Miton Glb Renewables Trust's score of 0.00 indicating that RTW Biotech Opportunities is being referred to more favorably in the media.
RTW Biotech Opportunities has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Comparatively, Premier Miton Glb Renewables Trust has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500.
RTW Biotech Opportunities has higher revenue and earnings than Premier Miton Glb Renewables Trust. Premier Miton Glb Renewables Trust is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.
Summary
RTW Biotech Opportunities beats Premier Miton Glb Renewables Trust on 9 of the 13 factors compared between the two stocks.
Get RTW Biotech Opportunities News Delivered to You Automatically
Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
RTW Biotech Opportunities Competitors List
Related Companies and Tools
This page (LON:RTW) was last updated on 9/14/2025 by MarketBeat.com Staff
Free RTW Stock Alerts